PharmTech LCGC Sciex Webinar 11.10
|Articles|August 3, 2009

LCGC Europe eNews

  • LCGC Europe eNews-07-31-2009
  • Volume 0
  • Issue 0

Agilent and Varian discuss the acquisition

It has been announced that Agilent Technologies will pay $1.5 billion, cash, for life sciences consumables and instrumentation supplier, Varian.

It has been announced that Agilent Technologies will pay $1.5 billion, cash, for life sciences consumables and instrumentation supplier, Varian.

"This acquisition is a major step in Agilent’s transformation into a leading bio-analytical measurement company," said Bill Sullivan, Agilent’s president and chief executive officer in a statement. He also indicated that the company’s biggest opportunities for growth in the future would be in bio-analytical measurement.

Agilent's press office told LC•GC Europe that, "The acquisition broadens Agilent’s applications and solutions offerings for mass spectrometry and chromatography; expands its product portfolio into atomic and molecular spectroscopy; establishes a leading position in nuclear magnetic resonance, imaging and vacuum technologies where Agilent does not currently participate; and strengthens its consumables portfolio."

"We both believe that our two companies will benefit by joining forces," said Varian in a statement to its employees. "Agilent has size, resources and global sales coverage that will enhance the growth of Varian businesses. Varian brings expertise and experience across different but complementary geographies and applications."

Varian went on to further describe these areas of expertise. "For instance, while Varian is well-established in energy and environmental applications, Agilent is a leader in food safety."

While the companies did not comment on any specific changes that customers would see as a result of the acquisition, an Agilent spokesperson did say that, "together, the combined company will be able to provide customers with a more comprehensive set of solutions across a wider range of industries."

Varian elaborated further: "Our customers will clearly benefit. We will be able to provide them with the most comprehensive set of solutions across a wider range of industries immediately after the transaction closes. And we will be better positioned than ever to create innovative new products and services in the future."

The acquisition is expected to close by the end of 2009, subject to regulatory approval.

For more on Agilent visit www.agilent.com

For more on Varian visit www.varianinc.com

Articles in this issue

over 17 years ago

GC Columns receive awards

Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.